DuPont Animal Nutrition announces manufacturing facility in Wuxi, China

DuPont announces opening of a new Animal Nutrition manufacturing capability in Wuxi, China.

New manufacturing plant will supply advanced customized solutions to animal nutrition industry

DuPont Nutrition & Biosciences (DuPont) announces the opening of a new Animal Nutrition manufacturing capability in Wuxi, China. The new plant operation will provide the local animal production industry with customized solutions according to DuPont’s global quality standards and advanced technology.

“This facility will improve the flexibility of our offerings to the Chinese animal nutrition market,” said Aart Mateboer, business unit director, Animal Nutrition. “We look forward to providing our key accounts a more customized offering, as well as a larger range of packaging sizes to better meet our customers’ needs. It provides us enhanced capabilities to launch many new products out of our global R&D pipeline to support the evolving needs of our customers in China”.

“We are pleased to add our Animal Nutrition products to the portfolio we support at our Wuxi facility, and offer world-class quality with very local customization to our China customers,” said Katariina Rasinmaki, global manufacturing and supply chain leader.

“We continue to enhance our capability to deliver solutions from our best in class product portfolio to our Asia Pacific customers,” said Vik Prabhu, regional director, Health & Biosciences, Asia Pacific. “We recently expanded our capability at our Shanghai Animal Nutrition Applications and Technical Service Laboratory, which is an excellent complement to this new operation. Due to African Swine Fever and COVID-19, our customers have adapted quickly to changing conditions and this facility is designed to provide flexible local response to our most valued customers.”

DuPont Animal Nutrition is a market leader in nutritional health solutions with a comprehensive portfolio of feed enzymes, betaine, phytogenics and probiotics. Through the lens of nutribiosis, DuPont invests in science and innovation to help producers improve performance, increase liveability and support welfare in the face of increasing pressure to reduce or remove antibiotics from production systems. DuPont Animal Nutrition capabilities are underpinned by the quality and quantity of our trials, including more than 80,000 guts sampled from over 500 farms, investments in omics technologies and microbiome research, and collaboration with leading commercial, governmental and academic partners. For more information, visit www.animalnutrition.dupont.com

 

Page 1 of 114
Next Page